Steven Valiquette
Stock Analyst at Mizuho
(2.98)
# 1,314
Out of 4,840 analysts
108
Total ratings
60.38%
Success rate
4.68%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Maintains: Neutral | $65 → $60 | $51.02 | +17.60% | 3 | May 16, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $250 → $245 | $170.80 | +43.44% | 11 | Apr 29, 2025 | |
| MCK McKesson | Maintains: Neutral | $630 → $690 | $716.09 | -3.64% | 3 | Apr 3, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $142 → $150 | $152.75 | -1.80% | 6 | Mar 31, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $21 → $18 | $15.47 | +16.35% | 7 | Mar 13, 2025 | |
| SOLV Solventum | Maintains: Neutral | $70 → $82 | $70.81 | +15.80% | 2 | Mar 3, 2025 | |
| VEEV Veeva Systems | Maintains: Outperform | $275 → $280 | $233.00 | +20.17% | 2 | Dec 9, 2024 | |
| LFMD LifeMD | Initiates: Neutral | $7 | $11.53 | -39.29% | 1 | Dec 4, 2024 | |
| HQY HealthEquity | Initiates: Outperform | $126 | $99.01 | +27.26% | 1 | Dec 4, 2024 | |
| HSIC Henry Schein | Initiates: Neutral | $75 | $71.65 | +4.68% | 5 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $2.82 | +77.30% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $20 | $16.72 | +19.62% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $14 | $6.45 | +117.05% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $142 | $186.21 | -23.74% | 10 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 | $64.12 | -14.22% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $82 → $92 | $149.17 | -38.33% | 10 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 | $295.57 | +91.16% | 5 | Apr 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $60.83 | +64.39% | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $14 | $4.58 | +205.68% | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $380 → $400 | $305.23 | +31.05% | 4 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $107 | $56.41 | +89.68% | 1 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $17 | $28.60 | -40.56% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5 → $12 | $6.41 | +87.21% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $96 | $118.70 | -19.12% | 3 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $105 → $120 | $171.23 | -29.92% | 6 | Apr 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $127 | $376.59 | -66.28% | 1 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $358 | $224.93 | +59.16% | 3 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $78 → $60 | $11.17 | +437.15% | 3 | Apr 3, 2019 |
Doximity
May 16, 2025
Maintains: Neutral
Price Target: $65 → $60
Current: $51.02
Upside: +17.60%
Align Technology
Apr 29, 2025
Maintains: Outperform
Price Target: $250 → $245
Current: $170.80
Upside: +43.44%
McKesson
Apr 3, 2025
Maintains: Neutral
Price Target: $630 → $690
Current: $716.09
Upside: -3.64%
Cardinal Health
Mar 31, 2025
Maintains: Outperform
Price Target: $142 → $150
Current: $152.75
Upside: -1.80%
DENTSPLY SIRONA
Mar 13, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $15.47
Upside: +16.35%
Solventum
Mar 3, 2025
Maintains: Neutral
Price Target: $70 → $82
Current: $70.81
Upside: +15.80%
Veeva Systems
Dec 9, 2024
Maintains: Outperform
Price Target: $275 → $280
Current: $233.00
Upside: +20.17%
LifeMD
Dec 4, 2024
Initiates: Neutral
Price Target: $7
Current: $11.53
Upside: -39.29%
HealthEquity
Dec 4, 2024
Initiates: Outperform
Price Target: $126
Current: $99.01
Upside: +27.26%
Henry Schein
Dec 4, 2024
Initiates: Neutral
Price Target: $75
Current: $71.65
Upside: +4.68%
Dec 4, 2024
Initiates: Outperform
Price Target: $5
Current: $2.82
Upside: +77.30%
Dec 4, 2024
Initiates: Underperform
Price Target: $20
Current: $16.72
Upside: +19.62%
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $6.45
Upside: +117.05%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $142
Current: $186.21
Upside: -23.74%
Aug 4, 2023
Maintains: Overweight
Price Target: $55
Current: $64.12
Upside: -14.22%
Aug 2, 2023
Maintains: Overweight
Price Target: $82 → $92
Current: $149.17
Upside: -38.33%
Apr 14, 2023
Maintains: Overweight
Price Target: $565
Current: $295.57
Upside: +91.16%
Mar 30, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $60.83
Upside: +64.39%
Feb 27, 2023
Maintains: Overweight
Price Target: $17 → $14
Current: $4.58
Upside: +205.68%
Oct 28, 2022
Maintains: Overweight
Price Target: $380 → $400
Current: $305.23
Upside: +31.05%
Jul 28, 2022
Reinstates: Overweight
Price Target: $107
Current: $56.41
Upside: +89.68%
Apr 18, 2022
Downgrades: Equal-Weight
Price Target: $22 → $17
Current: $28.60
Upside: -40.56%
Jun 11, 2021
Upgrades: Overweight
Price Target: $5 → $12
Current: $6.41
Upside: +87.21%
Nov 23, 2020
Upgrades: Overweight
Price Target: $96
Current: $118.70
Upside: -19.12%
Apr 30, 2020
Reiterates: Neutral
Price Target: $105 → $120
Current: $171.23
Upside: -29.92%
Apr 22, 2020
Maintains: Overweight
Price Target: $117 → $127
Current: $376.59
Upside: -66.28%
Dec 6, 2019
Maintains: Overweight
Price Target: $327 → $358
Current: $224.93
Upside: +59.16%
Apr 3, 2019
Maintains: Equal-Weight
Price Target: $78 → $60
Current: $11.17
Upside: +437.15%